Mount Vernon Hospital
- h-index: 49
- Total citations: 14,530
- Total papers: 309
Recent papers from Mount Vernon Hospital
- 2 Relationships Between Plasma KIM-1 Levels, Peripheral Immune Profiles and Disease-Free Survival Outcomes in the TransRAMPART StudyThe Oncologist · 2026
- 44 UK radiotherapy practice in volume delineation–data from the APPROACH trial (ISRCTN:1339049) radiotherapy quality assurance (RTQA) programme benchmark outlining caseNeuro-Oncology · 2026
- Artificial Intelligence–Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning AssistantJCO Global Oncology · 2026
- Impact of dose reporting modes on dosimetric accuracy in a national end-to-end stereotactic spine radiotherapy auditPhysics and Imaging in Radiation Oncology · 2026
- Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudyThe Lancet Oncology · 2026
- Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-study.2026
- Will upright radiotherapy become a new standard? STAND: Perspectives and acceptability from the global radiotherapy communityTechnical Innovations & Patient Support in Radiation Oncology · 2026
- Detection of errors in organs at risk delineations for radiotherapy for clinical trial reviewsPhysics in Medicine and Biology · 2026
- A comparison of sensitivity and specificity of dosimetry audits for intensity modulated radiation therapy used internationally for clinical trial credentialingRadiotherapy and Oncology · 2026
- PS5-09-12: Small: open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer - a UK phase III randomised multi-centre trialClinical Cancer Research · 2026
- PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTClinical and Translational Radiation Oncology · 2026
- Electromyography analysis of rotator cuff activation while drivingJSES International · 2025
- Uk Radiotherapy Practice for Oligodendroglioma –Data From the Approach Trial (Isrctn:1339049) Radiotherapy Quality Assurance (Rtqa) ProgrammeNeuro-Oncology · 2025
- Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical careTechnical Innovations & Patient Support in Radiation Oncology · 2025
- Normal tissue outlining guidelines development for soft tissue sarcoma of the extremitiesClinical and Translational Radiation Oncology · 2025
- Predicting acute diarrhoea in rectal cancer chemoradiotherapy: Secondary analysis of the phase III ARISTOTLE trialRadiotherapy and Oncology · 2025
- Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialThe Lancet Oncology · 2025
- Developing reference plans for evaluating global clinical trials credentialing and PSQA systemsJournal of Applied Clinical Medical Physics · 2025
- Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical CancerInternational Journal of Radiation Oncology*Biology*Physics · 2025
- Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-studyRadiotherapy and Oncology · 2025